Dennis M. Lanfear, President and CEO at Coherus BioSciences, Inc. (CHRS), sold 2,900 shares at $31.79 ($92K) on 2016-09-16, disclosed to the SEC on 2016-09-20.
Open-market sale of $92k CHRS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CHRS | SELL | 2019-11-25 | $464K | — | Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |